Viewing Study NCT00483366


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-02-20 @ 12:49 AM
Study NCT ID: NCT00483366
Status: COMPLETED
Last Update Posted: 2024-09-23
First Post: 2007-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
Sponsor: University of Nebraska
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unspecified adult solid tumor, protocol specific View